Labviva Announces $8M Series Seed Capital Raise
06/21/21, 12:02 PM
Location
cambridgeMoney raised
$8 million
Round Type
seed
Labviva, a leading SaaS application for healthcare procurement today announced an $8M Series Seed capital raise to support further development of the platform with new product lines, including investment in operations and customer success platforms. The funding closed on June 2, 2021. Led by Senator Investment Group, with other new investment from B Capital Group | Ascent and continued participation from Glasswing Ventures which led previous rounds to date.
Company Info
Location
cambridge, maryland, united states
Additional Info
Labviva connects researchers with suppliers of reagents, chemicals, and instrumentation in an intuitive user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage their content of their products, and products are mapped into scientific applications, techniques and protocols. Learn more about how Labviva accelerates the science of life at Labviva.com